AGER and metabolic dysfunction-associated steatotic liver disease: Our data indicate that oral DPS administration significantly increases serum pyridoxamine concentrations in NAFLD mice, suggesting that this elevation may suppress AGEs-RAGE pathway activation, thereby mitigating inflammation and oxidative stress in NAFLD.